The Centers for Disease Control and Prevention is clarifying its guidelines on opioid prescribing, citing the findings of a review panel that many clinicians, policymakers and payers are misapplying the CDC’s guidelines, and those actions are negatively affecting patients.
Misapplication of opioid guidelines?
The Centers for Disease Control and Prevention is clarifying its guidelines on opioid prescribing, citing the findings of a review panel that many clinicians, policymakers and payers are misapplying the CDC’s guidelines, and those actions are negatively affecting patients.